NBIX
Price
$138.02
Change
-$0.61 (-0.44%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
13.77B
84 days until earnings call
Intraday BUY SELL Signals
TKNO
Price
$4.42
Change
+$0.02 (+0.45%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
236.6M
118 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NBIX vs TKNO

Header iconNBIX vs TKNO Comparison
Open Charts NBIX vs TKNOBanner chart's image
Neurocrine Biosciences
Price$138.02
Change-$0.61 (-0.44%)
Volume$16.85K
Capitalization13.77B
Alpha Teknova
Price$4.42
Change+$0.02 (+0.45%)
Volume$1.69K
Capitalization236.6M
NBIX vs TKNO Comparison Chart in %
NBIX
Daily Signal:
Gain/Loss:
TKNO
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
NBIX vs. TKNO commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NBIX is a Hold and TKNO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (NBIX: $138.62 vs. TKNO: $4.42)
Brand notoriety: NBIX and TKNO are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: NBIX: 127% vs. TKNO: 82%
Market capitalization -- NBIX: $13.77B vs. TKNO: $236.6M
NBIX [@Pharmaceuticals: Generic] is valued at $13.77B. TKNO’s [@Pharmaceuticals: Generic] market capitalization is $236.6M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NBIX’s FA Score shows that 0 FA rating(s) are green whileTKNO’s FA Score has 0 green FA rating(s).

  • NBIX’s FA Score: 0 green, 5 red.
  • TKNO’s FA Score: 0 green, 5 red.
According to our system of comparison, NBIX is a better buy in the long-term than TKNO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NBIX’s TA Score shows that 3 TA indicator(s) are bullish while TKNO’s TA Score has 2 bullish TA indicator(s).

  • NBIX’s TA Score: 3 bullish, 6 bearish.
  • TKNO’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, NBIX is a better buy in the short-term than TKNO.

Price Growth

NBIX (@Pharmaceuticals: Generic) experienced а -5.89% price change this week, while TKNO (@Pharmaceuticals: Generic) price change was -9.80% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -3.77%. For the same industry, the average monthly price growth was -6.55%, and the average quarterly price growth was +28.28%.

Reported Earning Dates

NBIX is expected to report earnings on Feb 11, 2026.

TKNO is expected to report earnings on Mar 17, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-3.77% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NBIX($13.8B) has a higher market cap than TKNO($237M). NBIX YTD gains are higher at: 1.553 vs. TKNO (-47.066). NBIX has higher annual earnings (EBITDA): 613M vs. TKNO (-14.44M). NBIX has more cash in the bank: 1.12B vs. TKNO (24M). TKNO has less debt than NBIX: TKNO (29M) vs NBIX (428M). NBIX has higher revenues than TKNO: NBIX (2.68B) vs TKNO (38.9M).
NBIXTKNONBIX / TKNO
Capitalization13.8B237M5,823%
EBITDA613M-14.44M-4,245%
Gain YTD1.553-47.066-3%
P/E Ratio32.95N/A-
Revenue2.68B38.9M6,897%
Total Cash1.12B24M4,646%
Total Debt428M29M1,476%
FUNDAMENTALS RATINGS
NBIX: Fundamental Ratings
NBIX
OUTLOOK RATING
1..100
71
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
58
SMR RATING
1..100
53
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
34
SEASONALITY SCORE
1..100
14

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NBIXTKNO
RSI
ODDS (%)
Bearish Trend 2 days ago
59%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
53%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
55%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 14 days ago
72%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
NBIX
Daily Signal:
Gain/Loss:
TKNO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ANSNF0.05N/A
N/A
Anson Resources
KIERF2.75N/A
N/A
Kier Group Plc
OPHLF11.08N/A
N/A
Ono Pharmaceutical Co., Ltd.
HLNCF4.78-0.05
-1.04%
HALEON PLC
GPUSF0.05-0.01
-9.22%
ALSET AI VENTURES INC

TKNO and

Correlation & Price change

A.I.dvisor indicates that over the last year, TKNO has been loosely correlated with HROW. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if TKNO jumps, then HROW could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TKNO
1D Price
Change %
TKNO100%
+3.27%
HROW - TKNO
34%
Loosely correlated
-1.56%
AMRX - TKNO
33%
Loosely correlated
-0.04%
VTRS - TKNO
30%
Poorly correlated
+0.47%
ALKS - TKNO
30%
Poorly correlated
-0.34%
NBIX - TKNO
28%
Poorly correlated
-3.44%
More